openPR Logo
Press release

Oncology Anti-Cancer Drugs Market Set to Soar to USD 69.0 Billion by 2028, Aided by Technological Advances and Increasing Prevalence of Cancer

05-20-2024 04:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Dataintelo

/ PR Agency: Dataintelo


Dataintelo has recently published a comprehensive report revealing that the Global Oncology Anticancer Drugs Market is poised to soar from USD 39.25 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2021 to an impressive USD 69.0 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2028. This remarkable expansion, reflecting a Compound Annual Growth Rate (๐‚๐€๐†๐‘) of approximately 11% throughout the forecast period (2021-2028), is largely driven by the surging prevalence of cancer cases worldwide.

There's been an alarming rise in both the incidence and mortality rate of various types of cancers. According to Dataintelo, factors such as an aging population (specifically those within the 60-80 year age range) where the likelihood of developing cancer diseases is higher, have significantly contributed to the market growth. Simultaneously, continual technological advances in the Oncology Drug discovery pipeline combined with improved efficacy rates are boosting the surge and shaping the dynamics of the Oncology Anticancer Drugs market.

These developments in the Oncology Drug discovery pipeline offer potentially transformative therapies that are encouraging investment and efforts for increasing R&D innovation. The report further elaborates that the market is expected to observe a further rise due to changing lifestyle habits and genetic disorders which are significantly contributing to the rise in cancer cases.

The impressive potential of this multifaceted market indicates that the global Oncology Anticancer Drugs sector is a critical field for continual growth and exploration. This report provides key insights for investors, researchers, service providers, and other stakeholders to understand market dynamics and devise fruitful strategies for the future. Dataintelo's market analysis is a comprehensive guide to understanding the key market trends, dynamics, and growth factors shaping the future of the Oncology Anticancer Drugs industry

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @

๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐œ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

The oncology anti cancer drugs market has been segmented on the basis of๐“๐ฒ๐ฉ๐ž
โ— Blood Cancer
โ— Breast Cancer
โ— Gastrointestinal Cancer
โ— Prostate Cancer
โ— Lung Cancer
โ— Skin Cancer
โ— Others

๐ƒ๐ซ๐ฎ๐  ๐‚๐ฅ๐š๐ฌ๐ฌ
โ— Cytotoxic Agents
โ— Targeted Agents
โ— Hormonal Agents
โ— Immunotherapeutics
โ— Others

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐‚๐ก๐ž๐ฆ๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ, ๐“๐š๐ซ๐ ๐ž๐ญ๐ž๐ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ, ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ
โ— Chemotherapy
โ— Targeted Therapy
โ— Immunotherapy Biologic Therapy

๐‡๐จ๐ซ๐ฆ๐จ๐ง๐š๐ฅ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ, ๐๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ๐ข๐ณ๐ž๐ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž, ๐’๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ฏ๐ž ๐‚๐š๐ซ๐ž, ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ), ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ
โ— Hospital Pharmacy
โ— Retail Pharmacy
โ— Online Pharmacy

๐‘๐ž๐ ๐ข๐จ๐ง
โ— Asia Pacific
โ— North America
โ— Latin America
โ— Europe
โ— Middle East & Africa

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ
โ— Roche
โ— Novartis
โ— Celgene
โ— Amgen
โ— Johnson & Johnson
โ— GlaxoSmithKline
โ— Eli lilly & Co
โ— Pfizer
โ— Merck & Co.
โ— Sanofi

The oncology anti-cancer drugs market, a multi-faceted industry, has been categorized based on several parameters. The segmentation based on the type includes diverse genres of cancers such as blood, breast, gastrointestinal, prostate, lung, and skin cancer among others. The market fragmentation extends further to the classification of drug classes involving cytotoxic agents, targeted agents, hormonal agents, immunotherapeutics, and others. Additionally, these drugs find applications in a varied range of therapies like chemotherapy, targeted therapy, immunotherapy, biologic therapy, hormonal therapy, personalized medicine, supportive care, and more.

Regionally, the market encompasses areas such as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. The North American region, with its advanced healthcare infrastructure and high rate of cancer incidence, holds a significant share of the oncology anti-cancer drugs market. Meanwhile, the Asia Pacific region is showcasing promising growth due to an increase in healthcare expenditure and evolving medical infrastructure. The key players shaping the regional market landscape include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli Lilly & Co, Pfizer, Merck & Co, and Sanofi. These corporations are intensifying the competition with their continuous innovation and strategic collaborations. The various distribution channels involved range from hospital pharmacies, retail pharmacies to online pharmacies, meeting the diverse needs of the patients, thereby offering a robust supply chain and wide availability of these life-saving drugs

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ for Oncology Anti-Cancer Drugs Market:

1. Increasing Incidence of Cancer: The significant rise in the number of cancer cases globally is a key driver propelling the demand for oncology anti-cancer drugs.

2. Technological Advancements: Advancements in technology have made it possible to develop targeted therapies and personalized medicines, further driving the market growth.

3. Increase in Healthcare Expenditure and Insurance Coverage: Improved healthcare infrastructure and increased spending in emerging economies leads to greater accessibility of treatment options.

4. Rising Demand for Effective Treatment Methods: Patients and healthcare providers are constantly looking for more effective and less harmful treatment options.

5. Growing Geriatric Population: There is an increase in cancer prevalence in the aging population, leading to a higher demand for anti-cancer drugs.

6. R&D Investment: Pharmaceutical companies are increasingly investing in research and development for innovative drugs.

๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซOncology Anti-Cancer Drugs Market:

1. Innovative Drug Development: Innovative drug development through targeted therapy and immuno-oncology drugs proves to be a lucrative opportunity in the market.

2. Emerging markets: Developing countries provide a significant opportunity due to a high unmet need in these regions, coupled with improving healthcare infrastructure.

3. Collaboration and Merger & Acquisitions: Partnerships and collaborations between pharma-biotech companies for the co-development and commercialization of drugs present a substantial opportunity.

4. Personalized Medicine: Advances in genomics and personalized medicine have opened new ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซthe development of effective anti-cancer drugs.

5. Increase in Cancer Awareness Programs: Increased public and private initiatives in cancer awareness and early detection can create significant ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซmarket expansion.

6. Advances in Drug Delivery Systems: Development of new drug delivery systems which can enhance the efficacy of drugs by target specific delivery can also provide substantial opportunities in this market

๐˜๐จ๐ฎ ๐œ๐š๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐ซ๐จ๐ฆ:

This report should be purchased by businesses, analysts, strategists, SEO professionals, digital marketers, enterprises, and corporations interested in learning about specific market trends, competitive landscapes, and making data-driven decisions. Venture capitalists, investors, and government organizations looking to gain insights on market behavior and future predictions would also find this report beneficial.

Dataintelo offers comprehensive market research solutions that are backed by thorough research and analysis. They offer real-time data that are collected from reliable sources, ensuring the accuracy and timeliness of the information provided. Dataintelo provides extensive market insights, helping businesses understand their competitive position and optimize their strategies. They provide customized reports tailored to the specific needs of a business, making them a versatile choice for different industries. Their proactive approach to uncovering business trends and opportunities helps businesses stay ahead of the competition. In short, Dataintelo offers a combination of detail-oriented and big picture analysis, giving businesses a comprehensive understanding of their market

Contact Us :
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email -
Website -
Address - 500 East E Street, Ontario, CA 91764, United States.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ง ๐›๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐š๐ฌ ๐ฉ๐ž๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ง๐ž๐ž๐.

๐„๐ฆ๐š๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง - ๐ฌ๐š๐ฅ๐ž๐ฌ@๐๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ.๐œ๐จ๐ฆ

๐€๐›๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ:

๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Anti-Cancer Drugs Market Set to Soar to USD 69.0 Billion by 2028, Aided by Technological Advances and Increasing Prevalence of Cancer here

News-ID: 3504227 • Views: โ€ฆ

More Releases from Dataintelo

Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of XX%, Segmented by Type, Manufacturing Process, Application, and More, Reveals Dataintelo Report
Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of โ€ฆ
Dataintelo has recently unveiled a comprehensive analysis on the Carbon Carbon Composite Brake Disc Market in its latest report. The research, which is segmented by Type (2D C/C composite, 2.5D C/C composite, 3D C/C composite), by Manufacturing Process (Blow Moulding, Injection Moulding) and by Application (Motorsport, Aerospace, Heavy Vehicles), among other factors, anticipates the market to grow at a significant CAGR of XX% during the forecast period. The report considersโ€ฆ
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in Dataintelo's Latest Research Report Covering In-Depth Analysis of Leading Players and Key Sectors
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in โ€ฆ
Dataintelo has recently published a comprehensive study on the AR Optical Waveguide Module Market, revealing a forecast annual growth rate (CAGR) of XX%. The report is detailed and breaks down its research by aspects such as Light Detection (Infrared, Ultraviolet, Visible Light), Waveguide Type (Planar Waveguide, Channel Waveguide), Material Type (Polymer, LiNbO3, Glass, Silicon), Application (Telecommunication, Healthcare, Industrial, Aerospace and Defense), and Component (Input/Output Coupler, Waveguide Core, Cladding). The report segmentsโ€ฆ
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Players ABB Group, Yaskawa Electric Corporation, and Fanuc Corporation
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Pla โ€ฆ
In a newly published report from Dataintelo, it is revealed that the 6-Axis Robots Market is projected to experience a substantial growth, marking a significant CAGR in the forecast period. The comprehensive study is segmented by type, including Articulated, Cylindrical, Spherical, and Cartesian robots, and by application, encompassing Material Handling, Welding, Painting, and Assembly amongst others. Additionally, it explores various end-use industries, such as Automotive, Electrical and Electronics, Metals andโ€ฆ
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study on Product Types, Applications, End-users, and Key Players
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study โ€ฆ
In an insightful investigation of the Mesotherapy Market, Dataintelo unveils a comprehensive analysis of the key growth markers, restraints, and business prospects that will shape the industry dynamics in the coming years. The report is segmented by Product Type (Plant Extracts, Hormones, Enzymes, Vitamins, Others), by Application (Non-Surgical Liposuction, Body Contouring, Hair Restoration, Others), by End-user (Hospitals, Speciality Clinics, Aesthetic Centers), and by Technique (Nappage, Point by Point, Mesoperfusion, Mesolift,โ€ฆ

All 5 Releases

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โ€ฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™, detailing every single market driver and intricately analyzing the business vertical. This โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drugโ€ฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ€” industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโ€ฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymeraseโ€ฆ
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals โ€ฆ
AstraZenecaโ€™s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devicโ€™s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioningโ€ฆ
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and โ€ฆ
This yearโ€™s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drugโ€ฆ